title: Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan.
abstract: In a preliminary study carried out in the study area we found that 19.1% (173/907) of patients with chronic liver disease and 51% (35/68) of hepatocellular carcinoma cases were infected with Japanese schistosomiasis. Analysis of data from 571 autopsies revealed a similarly high incidence of schistosomiasis among cases of hepatoma and other liver diseases. A prospective case-control study conducted over 10 years showed that hepatoma developed in 5.4% (26/484) of chronic schistosomiasis cases and in 7.5% (23/307) of patients with chronic liver disease (hepatitis, cirrhosis, etc). The difference was not statistically significant (P = 0.228). A high incidence of hepatitis C virus (HCV) antibody (HCVAb) was found in the schistosomiasis group (36.5%; 95% CI = 44.9-28.1%) and in the chronic liver disease group (56.0%), 39% of whom had chronic hepatitis (P = 0.028). Various factors that might have contributed to the development of hepatoma and schistosomiasis were investigated, but no evidence of a significant correlation between schistosomiasis and hepatoma was found. The high incidence of HCVAb was considered to have been responsible for the development of hepatocellular carcinoma in chronic schistosomiasis patients. The role of HBV infection in the development of hepatoma in schistosomiasis patients was not confirmed after an assay for HCVAb was included in the study.
authors.affiliation: Yamanashi Kosei Hospital, Kofu City, Japan.
authors.forename: F
authors.initials: F
authors.lastname: Iida
authors.forename: R
authors.initials: R
authors.lastname: Iida
authors.forename: H
authors.initials: H
authors.lastname: Kamijo
authors.forename: K
authors.initials: K
authors.lastname: Takaso
authors.forename: Y
authors.initials: Y
authors.lastname: Miyazaki
authors.forename: W
authors.initials: W
authors.lastname: Funabashi
authors.forename: K
authors.initials: K
authors.lastname: Tsuchiya
authors.forename: Y
authors.initials: Y
authors.lastname: Matsumoto
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000453:epidemiology; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D002908:Chronic Disease; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000453:epidemiology; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008109:Liver Diseases, Parasitic / Q000150:complications* / Q000453:epidemiology; D008113:Liver Neoplasms / Q000150:complications* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012554:Schistosomiasis japonica / Q000150:complications* / Q000453:epidemiology; D018709:Statistics, Nonparametric